pubmed-article:16539678 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16539678 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
pubmed-article:16539678 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
pubmed-article:16539678 | lifeskim:mentions | umls-concept:C0040627 | lld:lifeskim |
pubmed-article:16539678 | lifeskim:mentions | umls-concept:C0039082 | lld:lifeskim |
pubmed-article:16539678 | lifeskim:mentions | umls-concept:C0011155 | lld:lifeskim |
pubmed-article:16539678 | lifeskim:mentions | umls-concept:C0040649 | lld:lifeskim |
pubmed-article:16539678 | lifeskim:mentions | umls-concept:C1710082 | lld:lifeskim |
pubmed-article:16539678 | lifeskim:mentions | umls-concept:C0599894 | lld:lifeskim |
pubmed-article:16539678 | lifeskim:mentions | umls-concept:C0439662 | lld:lifeskim |
pubmed-article:16539678 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:16539678 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:16539678 | lifeskim:mentions | umls-concept:C1533157 | lld:lifeskim |
pubmed-article:16539678 | lifeskim:mentions | umls-concept:C1506009 | lld:lifeskim |
pubmed-article:16539678 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:16539678 | pubmed:dateCreated | 2006-4-25 | lld:pubmed |
pubmed-article:16539678 | pubmed:abstractText | Impaired inflammatory functions may be critical factors in the mechanisms of severe CNS disorders classified as the human immunodeficiency virus-1 (HIV-1)-associated dementia (HAD). Evidence indicates that a viral gene product, the transactivator of transcription protein (Tat), can markedly contribute to these events. We herein report that sulfated polymannuroguluronate (SPMG), a novel anti-acquired immunodeficiency syndrome drug candidate now in a phase II clinical trial, significantly reversed Tat-induced release of pro-inflammatory cytokines [tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta) and IL-6] and dose dependently decreased the accumulation of reactive oxygen species and nitric oxide in THP-1 cells. Furthermore, SPMG potently arrested Tat-triggered protein kinase C (PKC)-dependent PKC-mu activation, and blocked the downstream extracellular-signal regulated kinase 1/2- and c-jun amino-terminal kinase-mediated signalling pathways. These molecular mechanisms could be attributed to the fact that SPMG preferentially bound to the basic domain (amino acids 47-57) of the Tat protein with high affinity (K(D) approximately 8.69 x 10(-10) m), leading to abrogation of Tat-mediated neuroinflammation and neurotoxicity. These data demonstrate that SPMG might serve as a valuable therapeutic intervention for Tat-induced profound pro-inflammatory effects in the brain, and subsequent pathologic events of HAD. | lld:pubmed |
pubmed-article:16539678 | pubmed:language | eng | lld:pubmed |
pubmed-article:16539678 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16539678 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16539678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16539678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16539678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16539678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16539678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16539678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16539678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16539678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16539678 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16539678 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16539678 | pubmed:month | Apr | lld:pubmed |
pubmed-article:16539678 | pubmed:issn | 0022-3042 | lld:pubmed |
pubmed-article:16539678 | pubmed:author | pubmed-author:ArkJ WJW | lld:pubmed |
pubmed-article:16539678 | pubmed:author | pubmed-author:RamS BSB | lld:pubmed |
pubmed-article:16539678 | pubmed:author | pubmed-author:LiJingJ | lld:pubmed |
pubmed-article:16539678 | pubmed:author | pubmed-author:AiJingJ | lld:pubmed |
pubmed-article:16539678 | pubmed:author | pubmed-author:GengMeiyuM | lld:pubmed |
pubmed-article:16539678 | pubmed:author | pubmed-author:WangLimeiL | lld:pubmed |
pubmed-article:16539678 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16539678 | pubmed:volume | 97 | lld:pubmed |
pubmed-article:16539678 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16539678 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16539678 | pubmed:pagination | 334-44 | lld:pubmed |
pubmed-article:16539678 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:meshHeading | pubmed-meshheading:16539678... | lld:pubmed |
pubmed-article:16539678 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16539678 | pubmed:articleTitle | Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein. | lld:pubmed |
pubmed-article:16539678 | pubmed:affiliation | Department of Pharmacology, Marine Drug and Food Institute, Ocean University of China, Qingdao. | lld:pubmed |
pubmed-article:16539678 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16539678 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:16539678 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16539678 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16539678 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16539678 | lld:pubmed |